Company
Qilu Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Dose 1 of QLS1410 | Phase 2 | Uncontrolled Hypertension |
Latest
No recent events.
Follow Qilu Pharmaceutical Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.